HK Stock Market Move | MEDLIVE (02192) fell more than 5% during trading hours. Net profit in the first half of the year increased by 5.9% year-on-year. The interim dividend was reduced to 11.66 cents.

MEDLIVE (02192) fell more than 5% during the trading session, with a decrease of 4.3% at the time of this report, to HK$14.02, with a trading volume of HK$3244.76 million. In terms of news, MEDLIVE released its performance for the 6 months ending on June 30, 2025. The group achieved a revenue of 3.12 billion RMB, a year-on-year increase of 28.2%; the net profit attributable to the owners of the parent company was 1.55 billion RMB, a year-on-year increase of 5.9%; and the basic earnings per share was 21.2 cents. In addition, the board of directors decided to distribute a mid-term dividend of 11.66 cents per ordinary share in RMB, compared to 12.05 cents in the same period last year.